Daclizumab Hematologic Response [clinicaltrials_resource:NCT00001962/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Daclizumab Hematologic Response [clinicaltrials_resource:NCT00001962/outcome/1]
Bio2RDF identifier
NCT00001962/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00001962/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
The daclizumab hematologic res ...... closed due to lack of accrual.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
3 and 6 months
type [clinicaltrials_vocabulary:type]
alternate
Daclizumab Hematologic Response
@en
identifier
clinicaltrials_resource:NCT00001962/outcome/1
title
Daclizumab, 1 mg/kg of body we ...... er completion of the infusion.
@en
type
label
Daclizumab Hematologic Response [clinicaltrials_resource:NCT00001962/outcome/1]
@en